BSX:NYSE
Boston Scientific Corp
$42.98
arrow_downward
-0.28%(-0.12) 1D
$43.21
arrow_upward
+0.53% (+0.23)bedtimeAfter hours
Closed: Sep 11, 4:00:04 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$43.19
High
$43.55
Low
$42.80
Mkt. cap
62.29B
Avg. vol.
19.55M
Volume
26.99M
P/E ratio
17.43
52-wk high
$105.65
52-wk low
$42.20
EPS
$2.47
Beta
0.57
Shares outstanding
1.45B
No. of employees
59K
Open
$43.19
High
$43.55
Low
$42.80
Mkt. cap
62.29B
Avg. vol.
19.55M
Volume
26.99M
P/E ratio
17.43
52-wk high
$105.65
52-wk low
$42.20
EPS
$2.47
Beta
0.57
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Boston Scientific (BSX) Stock Looks Below Fair Value on Current Estimates
Trefis
·
1 day ago
Is This BSX Stock Pullback Worth The Patience?
Seeking Alpha
·
1 day ago
Boston Scientific: $43 Finally Prices In A Bad 2026 (NYSE:BSX)
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com